Erratum: Randomized clinical trial of mast cell inhibition in patients with a medium-sized abdominal aortic aneurysm (Br J Surg (2015) 102 894-901 (DOI: 10.1002/bjs.9824));Randomized clinical trial of mast cell inhibition in patients with a medium-sized abdominal aortic aneurysm

British Journal of Surgery

Volumn 102, Issue 8, 2015, Pages 894-901

  Sillesen, H ^a   Eldrup, N ^b   Hultgren, R ^c   Lindeman, J ^f   Bredahl, K ^a   Thompson, M ^g   Wanhainen, A ^d   Wingren, U ^e   Swedenborg, J ^c  

^a Rigshospitalet   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^e SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^f LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^g ST GEORGE'S UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI-INFLAMMATORY AGENTS; PEMIROLAST; PYRIDINES; PYRIMIDINONES;

AGED; AGED, 80 AND OVER; AORTIC ANEURYSM, ABDOMINAL; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE-BLIND METHOD; DRUG EFFECTS; FEMALE; HUMANS; MALE; MAST CELLS; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL; ULTRASONOGRAPHY;

AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS; AORTIC ANEURYSM, ABDOMINAL; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MAST CELLS; MIDDLE AGED; PYRIDINES; PYRIMIDINONES;

EID: 84931574423     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.10114     Document Type: Erratum

References (34)

1. Nordon IM, Hinchliffe RJ, Loftus IM, Thompson MM,. Pathophysiology and epidemiology of abdominal aortic aneurysms. Nat Rev Cardiol 2011; 8: 92-102.
2. Kaartinen M, Penttila A, Kovanen PT,. Mast cells of two types differing in neutral protease composition in the human aortic intima. Demonstration of tryptase- and tryptase/chymase-containing mast cells in normal intimas, fatty streaks, and the shoulder region of atheromas. Arterioscler Thromb 1994; 14: 966-972.
3. Tsuruda T, Kato J, Hatakeyama K, Kojima K, Yano M, Yano Y, etal. Adventitial mast cells contribute to pathogenesis in the progression of abdominal aortic aneurysm. Circ Res 2008; 102: 1368-1377.
4. Sun J, Zhang J, Lindholt JS, Sukhova GK, Liu J, He A, etal. Critical role of mast cell chymase in mouse abdominal aortic aneurysm formation. Circulation 2009; 120: 973-982.
5. Furubayashi K, Takai S, Jin D, Miyazaki M, Katsumata T, Inagaki S, etal. Chymase activates promatrix metalloproteinase-9 in human abdominal aortic aneurysm. Clin Chim Acta 2008; 388: 214-216.
6. Wang Y, Shi GP,. Mast cell chymase and tryptase in abdominal aortic aneurysm formation. Trends Cardiovasc Med 2012; 22: 150-155.
7. Sakalihasan N, Delvenne P, Nusgens BV, Limet R, Lapiere CM,. Activated forms of MMP2 and MMP9 in abdominal aortic aneurysms. J Vasc Surg 1996; 24: 127-133.
8. Gruber BL, Marchese MJ, Suzuki K, Schwartz LB, Okada Y, Nagase H, etal. Synovial procollagenase activation by human mast cell tryptase dependence upon matrix metalloproteinase 3 activation. J Clin Invest 1989; 84: 1657-1662.
9. Saarinen J, Kalkkinen N, Welgus HG, Kovanen PT,. Activation of human interstitial procollagenase through direct cleavage of the Leu83-Thr84 bond by mast cell chymase. J Biol Chem 1994; 269: 18134-18140.
10. Furubayashi K, Takai S, Jin D, Muramatsu M, Ibaraki T, Nishimoto M, etal. The significance of chymase in the progression of abdominal aortic aneurysms in dogs. Hypertens Res 2007; 30: 349-357.
11. Saren P, Welgus HG, Kovanen PT,. TNF-alpha and IL-1beta selectively induce expression of 92-kDa gelatinase by human macrophages. J Immunol 1996; 157: 4159-4165.
12. Kaschina E, Scholz H, Steckelings UM, Sommerfeld M, Kemnitz UR, Artuc M, etal. Transition from atherosclerosis to aortic aneurysm in humans coincides with an increased expression of RAS components. Atherosclerosis 2009; 205: 396-403.
13. Michel JB,. Anoikis in the cardiovascular system: known and unknown extracellular mediators. Arterioscler Thromb Vasc Biol 2003; 23: 2146-2154.
14. Kovanen PT,. Mast cells: multipotent local effector cells in atherothrombosis. Immunol Rev 2007; 217: 105-122.
15. Holmes DR, Liao S, Parks WC, Thompson RW,. Medial neovascularization in abdominal aortic aneurysms: a histopathologic marker of aneurysmal degeneration with pathophysiologic implications. J Vasc Surg 1995; 21: 761-771.
16. Mayranpaa MI, Trosien JA, Fontaine V, Folkesson M, Kazi M, Eriksson P, etal. Mast cells associate with neovessels in the media and adventitia of abdominal aortic aneurysms. J Vasc Surg 2009; 50: 388-395.
17. Swedenborg J, Mayranpaa MI, Kovanen PT,. Mast cells: important players in the orchestrated pathogenesis of abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 2011; 31: 734-740.
18. Kurosawa K, Matsumura JS, Yamanouchi D,. Current status of medical treatment for abdominal aortic aneurysm. Circ J 2013; 77: 2860-2866.
19. Meijer CA, Stijnen T, Wasser MN, Hamming JF, van Bockel JH, Lindeman JH,; Pharmaceutical Aneurysm Stabilisation Trial Study Group. Doxycycline for stabilization of abdominal aortic aneurysms: a randomized trial. Ann Intern Med 2013; 159: 815-823.
20. Tsunemi K, Takai S, Nishimoto M, Jin D, Sakaguchi M, Muramatsu M, etal. A specific chymase inhibitor, 2-(5-formylamino-6-oxo-2-phenyl-1,6-dihydropyrimidine-1-yl)-N-[[3,4-dioxo-1-pheny l-7-(2-pyridyloxy)]-2-heptyl]acetamide (NK3201), suppresses development of abdominal aortic aneurysm in hamsters. J Pharmacol Exp Ther 2004; 309: 879-883.
21. Sun J, Sukhova GK, Yang M, Wolters PJ, MacFarlane LA, Libby P, etal. Mast cells modulate the pathogenesis of elastase-induced abdominal aortic aneurysms in mice. J Clin Invest 2007; 117: 3359-3368.
22. Bredahl K, Eldrup N, Meyer C, Eiberg JE, Sillesen H,. Reproducibility of ECG-gated ultrasound diameter assessment of small abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 2013; 45: 235-240.
23. Moll FL, Powell JT, Friedrich G, Verzini F, Haulon S, Waltham M, etal.; European Society for Vascular Surgery. Management of abdominal aortic aneurysms-clinical practice guidelines of the European Society for Vascular Surgery. Eur J Vasc Endovasc Surg 2011; 41 (Suppl 1): S1-S58.
24. Rughani G, Robertson L, Clarke M,. Medical treatment of small abdominal aortic aneurysms. Cochrane Database Syst Rev 2012; (9)CD009536.
25. Kushner I., C-reactive protein elevation can be caused by conditions other than inflammation and may reflect biologic aging. Cleve Clin J Med 2001; 68: 535-537.
26. Norman P, Spencer CA, Lawrence-Brown MM, Jamrozik K,. C-reactive protein levels and the expansion of screen-detected abdominal aortic aneurysms in men. Circulation 2004; 110: 862-866.
27. Yoshimura K, Aoki H, Ikeda Y, Fujii K, Akiyama N, Furutani A, etal. Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase. Nat Med 2005; 11: 1330-1338.
28. Funk CD,. Leukotriene modifiers as potential therapeutics for cardiovascular disease. Nat Rev Drug Discov 2005; 4: 664-672.
29. Zhao L, Moos MP, Grabner R, Pedrono F, Fan J, Kaiser B, etal. The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm. Nat Med 2004; 10: 966-973.
30. Di Gennaro A, Wagsater D, Mayranpaa MI, Gabrielsen A, Swedenborg J, Hamsten A, etal. Increased expression of leukotriene C4 synthase and predominant formation of cysteinyl-leukotrienes in human abdominal aortic aneurysm. Proc Natl Acad Sci USA 2010; 107: 21093-21097.
31. Houard X, Touat Z, Ollivier V, Louedec L, Philippe M, Sebbag U, etal. Mediators of neutrophil recruitment in human abdominal aortic aneurysms. Cardiovasc Res 2009; 82: 532-541.
32. Grøndal N, Bramsen MB, Thomsen MD, Rasmussen CB, Lindholt JS,. The cardiac cycle is a major contributor to variability in size measurements of abdominal aortic aneurysms by ultrasound. Eur J Vasc Endovasc Surg 2012; 43: 30-33.
33. Beales L, Wolstenhulme S, Evans JA, West R, Scott DJ,. Reproducibility of ultrasound measurement of the abdominal aorta. Br J Surg 2011; 98: 1517-1525.
34. Rescan Collaborators, Bown MJ, Sweeting MJ, Brown LC, Powell JT, Thompson SG., Surveillance intervals for small abdominal aortic aneurysms. A metaanalysis. JAMA 2013; 309: 806-813.